Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
André J Scheen. (2015) Pharmacokinetics and clinical evaluation of the alogliptin plus pioglitazone combination for type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 11:6, pages 1005-1020.
Read now
Read now
André J Scheen. (2015) A review of gliptins for 2014. Expert Opinion on Pharmacotherapy 16:1, pages 43-62.
Read now
Read now
Articles from other publishers (3)
Marianne A. Mahrouse & Nesrine T. Lamie. (2019) Experimental design methodology for optimization and robustness determination in ion pair RP-HPLC method development: Application for the simultaneous determination of metformin hydrochloride, alogliptin benzoate and repaglinide in tablets. Microchemical Journal 147, pages 691-706.
Crossref
Crossref
Alina Y. Babenko, Anna A. Mosikian, Igor E. Makarenko, Victoriya V. Leusheva & Evgeny V. Shlyakhto. (2018) Efficacy and safety of evogliptin versus sitagliptin as add on to metformin alone in a combined russian-korean population. Evo-combi trial. Diabetes mellitus 21:4, pages 241-254.
Crossref
Crossref
Caroline Dudkowski, Max Tsai, Jie Liu, Zhen Zhao, Eric Schmidt & Jeannie Xie. (2016) The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus. European Journal of Clinical Pharmacology 73:3, pages 279-288.
Crossref
Crossref